down here at eleven times forward earnings for this health care titan. We could stay choppy and see lower prices first, but BDX will definitely continue to benefit from the increasing global demand and aging of the population (demographics strongly favor this company over time). Downside very limited (upper 60s) with an upside back to ninety.